Indivior Wins Temporary Block On Alvogen Suboxone Generic

Indivior Inc. on Thursday won a bid to temporarily block New Jersey-based Alvogen Pine Brook Inc. from selling a generic version of the opioid addiction treatment drug Suboxone, which is at the center of an ongoing patent row, according to an order from a Garden State federal judge…

Read this piece in its entirety at Law360.

Comments

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s